Deca-Durabolin and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with Deca-Durabolin (nandrolone).
High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia)
Major Potential Hazard, Moderate plausibility
androgens - hyperlipoproteinemia
Androgenic anabolic steroids may adversely affect serum lipids, including lowering HDL and elevating LDL levels. These changes can be marked, particularly with the 17-alpha-alkyl derivatives (i.e., fluoxymesterone, methyltestosterone, oxandrolone, oxymetholone, and stanozolol), and may significantly impact the risk of atherosclerosis and coronary artery disease. Patients with preexisting hyperlipoproteinemia may require closer monitoring during therapy with androgenic agents, and adjustments made accordingly in their lipid-lowering regimen. Androgen therapy should be administered cautiously in patients with coronary artery disease or a history of ischemic heart disease.
- "Product Information. Halotestin (fluoxymesterone)." Pharmacia and Upjohn (2001):
- "Product Information. Androderm (testosterone topical)." SmithKline Beecham (2001):
Deca-Durabolin drug interactions
There are 78 drug interactions with Deca-Durabolin (nandrolone).
Deca-Durabolin disease interactions
There are 10 disease interactions with Deca-Durabolin (nandrolone) which include:
- carcinoma (male)
- fluid retention
- hypercalcemia in breast cancer
- liver disease
- suppression of clotting factors
- thyroid function tests
More about Deca-Durabolin (nandrolone)
- Check interactions
- Side effects
- Dosage information
- During pregnancy
- Drug class: androgens and anabolic steroids
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.